Cargando…

Management of BMI Is a Potential New Approach for the Prevention of Idiopathic Pulmonary Fibrosis

Aims: Current idiopathic pulmonary fibrosis (IPF) therapies usually show a poor outcome or treatment efficacy. The search for new risk factors has significant implications in preventing, delaying, and treating IPF. The association between obesity and the risk of IPF is not clear. This study aimed to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Yuchao, Feng, Chang, Tang, Haibo, Deng, Peizhi, Li, Yalan, Wang, Jie, Zhu, Shaihong, Zhu, Liyong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8961741/ https://www.ncbi.nlm.nih.gov/pubmed/35360873 http://dx.doi.org/10.3389/fgene.2022.821029

Ejemplares similares

Transcriptome-wide association study-derived genes as potential visceral adipose tissue-specific targets for type 2 diabetes
por: Tang, Haibo, et al.
Publicado: (2023)

Relevance of RNA N6-Methyladenosine Regulators for Pulmonary Fibrosis: Implications for Chronic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis
por: Zhou, Yiyi, et al.
Publicado: (2022)

Corrigendum: Relevance of RNA N6-methyladenosine regulators for pulmonary fibrosis: Implications for chronic hypersensitivity pneumonitis and idiopathic pulmonary fibrosis
por: Zhou, Yiyi, et al.
Publicado: (2022)

Identification and Validation of Aging-Related Genes in Idiopathic Pulmonary Fibrosis
por: He, Jie, et al.
Publicado: (2022)

A potential three-gene-based diagnostic signature for idiopathic pulmonary fibrosis
por: Wu, Yi, et al.
Publicado: (2023)

Identification of immune biomarkers associated with basement membranes in idiopathic pulmonary fibrosis and their pan-cancer analysis
por: Fu, Chenkun, et al.
Publicado: (2023)

Identification and validation of metabolism-related hub genes in idiopathic pulmonary fibrosis
por: Zeng, Youjie, et al.
Publicado: (2023)

Prognostic analysis of m6A-related genes as potential biomarkers in idiopathic pulmonary fibrosis
por: Wang, Zhiqiang, et al.
Publicado: (2022)

Genes related to N6-methyladenosine in the diagnosis and prognosis of idiopathic pulmonary fibrosis
por: Zhang, Jingcheng, et al.
Publicado: (2023)

Identification of Hub Genes in Idiopathic Pulmonary Fibrosis and NSCLC Progression:Evidence From Bioinformatics Analysis
por: Yao, Yuanshan, et al.
Publicado: (2022)

Disease-specific mortality and major adverse cardiovascular events after bariatric surgery: a meta-analysis of age, sex, and BMI-matched cohort studies
por: Cui, Beibei, et al.
Publicado: (2023)

A prognostic model based on clusters of molecules related to epithelial–mesenchymal transition for idiopathic pulmonary fibrosis
por: Zhao, Jiarui, et al.
Publicado: (2023)

Identification of Potential Pathogenic Super-Enhancers-Driven Genes in Pulmonary Fibrosis
por: Li, Hang, et al.
Publicado: (2021)

Predictive investigation of idiopathic pulmonary fibrosis subtypes based on cellular senescence-related genes for disease treatment and management
por: Yang, Changqing, et al.
Publicado: (2023)

The Impact of ACEs on BMI: An Investigation of the Genotype-Environment Effects of BMI
por: Schlauch, Karen A., et al.
Publicado: (2022)

Bioinformatics Analysis Identifies Potential Ferroptosis Key Genes in the Pathogenesis of Pulmonary Fibrosis
por: He, Jie, et al.
Publicado: (2022)

Diagnostic accuracy of the visceral adiposity index in patients with metabolic-associated fatty liver disease: a meta-analysis
por: Yi, Xianhao, et al.
Publicado: (2022)

Integrative Analysis of Transcriptome-Wide Association Study and mRNA Expression Profiles Identifies Candidate Genes Associated With Idiopathic Pulmonary Fibrosis
por: Gong, Weiming, et al.
Publicado: (2020)

Construction and Validation of a Novel Prognostic Signature of Idiopathic Pulmonary Fibrosis by Identifying Subtypes Based on Genes Related to 7-Methylguanosine Modification
por: Huang, Tao, et al.
Publicado: (2022)

TyG Index Performs Better Than HOMA-IR in Chinese Type 2 Diabetes Mellitus with a BMI < 35 kg/m(2): A Hyperglycemic Clamp Validated Study
por: Luo, Ping, et al.
Publicado: (2022)

Development and Validation of a Novel Gene Signature for Predicting the Prognosis of Idiopathic Pulmonary Fibrosis Based on Three Epithelial-Mesenchymal Transition and Immune-Related Genes
por: Zheng, Jiafeng, et al.
Publicado: (2022)

Inflammatory Cytokines and Risk of Ischemic Stroke: A Mendelian Randomization Study
por: Li, Yalan, et al.
Publicado: (2022)

Correlation analysis between eGFR(cys) and SXscore in patients with diabetes
por: YONG, ZHONG, et al.
Publicado: (2014)

Approach to acute exacerbation of idiopathic pulmonary fibrosis
por: Bhatti, Hammad, et al.
Publicado: (2013)

BMI prediction within a Korean population
por: Lee, Jin Sol, et al.
Publicado: (2017)

Autophagy in Idiopathic Pulmonary Fibrosis
por: Patel, Avignat S., et al.
Publicado: (2012)

Progress in understanding and treating idiopathic pulmonary fibrosis: recent insights and emerging therapies
por: Guo, Hehua, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Identification and validation of targets of swertiamarin on idiopathic pulmonary fibrosis through bioinformatics and molecular docking-based approach
por: Chang, Jun, et al.
Publicado: (2023)

Nintedanib prevented fibrosis progression and lung cancer growth in idiopathic pulmonary fibrosis
por: Fukunaga, Kentaro, et al.
Publicado: (2018)

p21/Cyclin E pathway modulates anticlastogenic function of Bmi-1 in cancer cells
por: Deng, Wen, et al.
Publicado: (2015)

“Big Data” Approaches for Prevention of the Metabolic Syndrome
por: Jiang, Xinping, et al.
Publicado: (2022)

T cells in idiopathic pulmonary fibrosis: crucial but controversial
por: Deng, Lishan, et al.
Publicado: (2023)

Association of ABCG2 rs2231142 Allele and BMI With Hyperuricemia in an East Asian Population
por: Chen, Yen-Ju, et al.
Publicado: (2021)

Identifying potential biomarkers of idiopathic pulmonary fibrosis through machine learning analysis
por: Wu, Zenan, et al.
Publicado: (2023)

Monocyte as a prognostic marker in patients with idiopathic pulmonary fibrosis
por: Zhu, Shiping
Publicado: (2021)

The Role of Extracellular Vesicles in Idiopathic Pulmonary Fibrosis Progression: An Approach on Their Therapeutics Potential
por: Ramírez-Hernández, Alma Aurora, et al.
Publicado: (2022)

The Potential Effects of Curcumin on Pulmonary Fibroblasts of Idiopathic Pulmonary Fibrosis (IPF)—Approaching with Next-Generation Sequencing and Bioinformatics
por: Chang, Wei-An, et al.
Publicado: (2020)

Targeting survivin with Tanshinone IIA inhibits tumor growth and overcomes chemoresistance in colorectal cancer
por: Cao, Yaoquan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3vut2jai3qc9aiipkmr3j0upgr